Michael Thomas Henderson, Chief Executive Officer at Apogee Therapeutics, Inc. (APGE), sold 16,672 shares at $47.19 ($778K) on 2024-12-04, disclosed to the SEC on 2024-12-06.
Scheduled sale ($778k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $46.50 | 13,328 | $620K | 79.7% |
| 2 | $47.19 | 1,672 | $79K | 10.1% |
| 3 | $47.19 | 1,672 | $79K | 10.1% |
| Total | $46.64 avg | 16,672 | $778K | 100% |
| Filing → |
| SYRE | SELL | 2026-06-23 | $2.0M | — | Filing → |
| APGE | SELL | 2026-06-12 | $1.7M | — | Filing → |
| APGE | SELL | 2026-05-15 | $1.6M | — | Filing → |